We are proud to announce that PhenoPath is now a Quest Diagnostics Company.

News & Info

Find out what’s happening near you.

Latest News

  • PhenoPath conference March 7th

    Please read the attached letter regarding the PhenoPath conference scheduled for March 7th, 2019

    Read More »
  • PhenoPath acquired by Quest Diagnostics

    Please read the attached letter for an important announcement regarding PhenoPath

    Read More »
  • Phenomena v21.1

    New FDA Approvals for PD-L1/PD-1 Targeted Therapies & Introducing the Combined Positive Score (CPS); New Assays MUC4 IHC and TFE3 (Xp11) FISH; Amyloid Analysis;...

    Read More »